- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00744484
A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease
February 18, 2022 updated by: Norwegian University of Science and Technology
A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease (COPD)-a Comparison of Water Based and Land Based Group Training
The purpose of this study is to determine whether water based or land based group training is more effective for people with COPD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
COPD is a more common diagnosis today compared to 20 years ago, and the group is growing fast.
The suffering caused by COPD and the financial cost to society is on the increasing.
The principal causes of COPD are smoking and inactivity.
So far it is poorly understood wich form of exercise is the most effective in training this condition.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nord-Trøndelag
-
Levanger, Nord-Trøndelag, Norway, 7600
- Levanger Hosp
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COPD GOLD II
- Not taking part in physical activity during the last year
Exclusion Criteria:
- COPD GOLD I, III, IV
- Pain in the legs that make activity difficult
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: B1
B1 - training in water
|
45 minutes interval training in water, submaximal intensity, twice a week
|
Experimental: S1
S1 - training on land
|
45 minutes interval training on land, submaximal intensity, twice a week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
VO2 peak
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Health related quality of life
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Thor Naustdal, MD, Hospital of Levanger / NTNU ISB
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2008
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
August 29, 2008
First Submitted That Met QC Criteria
August 29, 2008
First Posted (Estimate)
September 1, 2008
Study Record Updates
Last Update Posted (Actual)
March 7, 2022
Last Update Submitted That Met QC Criteria
February 18, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4.2007.679 (REK)
- 17117 (NSD)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
Clinical Trials on Training in water
-
Federal University of Health Science of Porto AlegreRecruiting
-
University Hospital, MontpellierCompletedHealthy | Heat ExposureFrance
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
Federal University of PelotasCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
University Hospitals, LeicesterCompletedUlcerative Colitis | Lactose IntoleranceUnited Kingdom
-
CerecinCelerionCompleted
-
Federal University of PelotasUnknown
-
Pardis Specialized Wellness InstituteCompletedParkinson Disease | Neurologic Disorder | ParkinsonIran, Islamic Republic of